Advanced search
Publication Cover
Channels Volume 15, 2021 - Issue 1
Submit an article Journal homepage
2,741
Views
14
CrossRef citations to date
0
Altmetric
Brief Report

Trigeminal neuropathic pain is alleviated by inhibition of Cav3.3 T-type calcium channels in mice

Marena Monteraa Department of Anesthesiology and Critical Care Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USAView further author information
,
Aleyah Goinsa Department of Anesthesiology and Critical Care Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USAView further author information
,
Leos Cmarkob Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic;c Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech RepublicORCID Iconhttps://orcid.org/0000-0003-4272-2784View further author information
ORCID Icon,
Norbert Weissb Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic;c Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech RepublicORCID Iconhttps://orcid.org/0000-0002-0040-1109View further author information
ORCID Icon,
Karin N. Westlunda Department of Anesthesiology and Critical Care Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7388-4834View further author information
ORCID Icon &
Sascha R. A. Allesa Department of Anesthesiology and Critical Care Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8532-8950View further author information
ORCID Icon
Pages 31-37 | Received 29 Oct 2020, Accepted 26 Nov 2020, Published online: 23 Dec 2020

References

  • Montera M, Westlund K. Minimally invasive oral surgery induction of the FRICT-ION chronic neuropathic pain model. BIO-Protoc [Internet]. 2020 [cited 2020 Apr 20];10. Available from: https://bio-protocol.org/e3591
  • Gewandter JS, Dworkin RH, Turk DC, et al. Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations. Pain. 2015;156:1184–1197.
  • Cooper SA, Desjardins PJ. The value of the dental impaction pain model in drug development. Methods Mol Biol Clifton NJ. 2010;617:175–190.
  • Zhang M, Hu M, Montera MA, et al. Sustained relief of trigeminal neuropathic pain by a blood–brain barrier penetrable PPAR gamma agonist. Mol Pain [Internet]. 2019 [cited 2020 Oct 26];15:174480691988449. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843736/
  • Ma F, Zhang L, Lyons D, et al. Orofacial neuropathic pain mouse model induced by trigeminal inflammatory compression (TIC) of the infraorbital nerve. Mol Brain. 2012;5:44.
  • Bangash MA, Alles SRA, Santana-Varela S, et al. Distinct transcriptional responses of mouse sensory neurons in models of human chronic pain conditions. Wellcome Open Res [Internet]. 2018 [cited 2020 Oct 9];3:78. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053702/
  • Buonvicino D, Urru M, Muzzi M, et al. Trigeminal ganglion transcriptome analysis in 2 rat models of medication-overuse headache reveals coherent and widespread induction of pronociceptive gene expression patterns. Pain. 2018;159:1980–1988.
  • Danaher RJ, Zhang L, Donley CJ, et al. Histone deacetylase inhibitors prevent persistent hypersensitivity in an orofacial neuropathic pain model. Mol Pain [Internet]. 2018 [cited 2019 Aug 23];14:174480691879676. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124181/
  • Cmarko L, Weiss N. Selective inhibition of neuronal Cav3.3 T-type calcium channels by TAT-based channel peptide. Mol Brain. 2020;13:95.
  • Greenbaum D, Colangelo C, Williams K, et al. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 2003;4:117.
  • Talley EM, Cribbs LL, Lee J-H, et al. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci. 1999;19:1895–1911.
  • Snutch TP, Zamponi GW. Recent advances in the development of T-type calcium channel blockers for pain intervention. Br J Pharmacol. 2018;175:2375–2383.
  • Zamponi GW. Targeting voltage-gated calcium channels in neurological and psychiatric diseases. Nat Rev Drug Discov. 2016;15:19–34.
  • Gadotti VM, Caballero AG, Berger ND, et al. Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain. Mol Pain. 2015;11:12.
  • García-Caballero A, Gadotti VM, Stemkowski P, et al. The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity. Neuron. 2014;83:1144–1158.
  • Gomez K, Calderón-Rivera A, Sandoval A, et al. Cdk5-dependent phosphorylation of CaV3.2 T-type channels: possible role in nerve ligation-induced neuropathic allodynia and the compound action potential in primary afferent C fibers. J Neurosci Off J Soc Neurosci. 2020;40:283–296.
  • Shen F-Y, Chen Z-Y, Zhong W, et al. Alleviation of neuropathic pain by regulating T-type calcium channels in rat anterior cingulate cortex. Mol Pain. 2015;11:7.
  • Shin SM, Cai Y, Itson-Zoske B, et al. Enhanced T-type calcium channel 3.2 activity in sensory neurons contributes to neuropathic-like pain of monosodium iodoacetate-induced knee osteoarthritis. Mol Pain. 2020;16:1744806920963807.
  • Kerckhove N, Pereira B, Soriot-Thomas S, et al. Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial. Eur J Pain Lond Engl. 2018;22:1321–1330.
  • Wen X, Li Z, Chen Z, et al. Intrathecal administration of Cav3.2 and Cav3.3 antisense oligonucleotide reverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion. Acta Pharmacol Sin. 2006;27:1547–1552.
  • Choi S, Yu E, Hwang E, et al. Pathophysiological implication of CaV3.1 T-type Ca2+ channels in trigeminal neuropathic pain. Proc Natl Acad Sci U S A. 2016;113:2270–2275.
  • Bauer CS, Rahman W, Tran-van-Minh A, et al. The anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo. Biochem Soc Trans. 2010;38:525–528.
  • Bauer CS, Nieto-Rostro M, Rahman W, et al. The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. J Neurosci. 2009;29:4076–4088.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.